These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 21668398

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease.
    Locatelli F, Pagliara D.
    Pediatr Blood Cancer; 2012 Aug; 59(2):372-6. PubMed ID: 22544533
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome.
    Brachet C, Azzi N, Demulder A, Devalck C, Gourdin A, Gulbis B, Klein A, Le PQ, Loop M, Sariban E, Ferster A.
    Bone Marrow Transplant; 2004 Apr; 33(8):799-803. PubMed ID: 14767501
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic cellular gene therapy for hemoglobinopathies.
    Gaziev J, Lucarelli G.
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
    [Abstract] [Full Text] [Related]

  • 7. Stem cell transplantation after reduced-intensity conditioning for sickle cell disease.
    Matthes-Martin S, Lawitschka A, Fritsch G, Lion T, Grimm B, Breuer S, Boztug H, Karlhuber S, Holter W, Peters C, Minkov M.
    Eur J Haematol; 2013 Apr; 90(4):308-12. PubMed ID: 23369103
    [Abstract] [Full Text] [Related]

  • 8. Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape.
    Kassim AA, Sharma D.
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):259-266. PubMed ID: 28641096
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research.
    Panepinto JA, Walters MC, Carreras J, Marsh J, Bredeson CN, Gale RP, Hale GA, Horan J, Hows JM, Klein JP, Pasquini R, Roberts I, Sullivan K, Eapen M, Ferster A, Non-Malignant Marrow Disorders Working Committee, Center for International Blood and Marrow Transplant Research.
    Br J Haematol; 2007 Jun; 137(5):479-85. PubMed ID: 17459050
    [Abstract] [Full Text] [Related]

  • 12. Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia.
    Aversa F, Reisner Y, Martelli MF.
    Blood Cells Mol Dis; 2004 Jun; 33(3):294-302. PubMed ID: 15528148
    [Abstract] [Full Text] [Related]

  • 13. Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease.
    van Besien K, Bartholomew A, Stock W, Peace D, Devine S, Sher D, Sosman J, Chen YH, Koshy M, Hoffman R.
    Bone Marrow Transplant; 2000 Aug; 26(4):445-9. PubMed ID: 10982293
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sibling donor cord blood banking for children with sickle cell disease.
    Reed W, Walters M, Trachtenberg E, Smith R, Lubin BH.
    Pediatr Pathol Mol Med; 2001 Aug; 20(2):167-74. PubMed ID: 12673840
    [Abstract] [Full Text] [Related]

  • 16. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [Abstract] [Full Text] [Related]

  • 17. Identification of unrelated cord blood units for hematopoietic stem cell transplantation in children with sickle cell disease.
    Adamkiewicz TV, Boyer MW, Bray R, Haight A, Yeager AM.
    J Pediatr Hematol Oncol; 2006 Jan; 28(1):29-32. PubMed ID: 16394889
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies.
    Krishnamurti L, Abel S, Maiers M, Flesch S.
    Bone Marrow Transplant; 2003 Apr; 31(7):547-50. PubMed ID: 12692619
    [Abstract] [Full Text] [Related]

  • 20. Nonmyeloablative approaches to the treatment of sickle hemoglobinopathies.
    Amado RG, Schiller GJ.
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):82-9. PubMed ID: 10877059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.